Search Weight Loss Topics:




Nov 19

Lilly To Build 1st Factory in Germany as Demand for Weight-Loss … – Investopedia

Key Takeaways

Pharmaceuticals maker Eli Lilly (LLY) is building its first facility in Germany in response to the booming demand for weight-loss drugs.

Lilly reportedly said that it would be spending 2.3 billion euros ($2.5 billion) to construct the high-tech factory in Alzey, Germany. The drug maker noted the plant will further expand its injectable product and device manufacturing network and support an increased demand for Lillys medicines, including its diabetes and obesity portfolio.

Lillys injectable diabetes drug, Mounjaro, has been shown to help patients lose weight, and a second medicine, Zepbound, containing the active ingredient in Mounjaro, last week received Food and Drug Administration approval for use as a weight-loss treatment. That news sent Lilly shares to an all-time high.

With the addition of the Alzey location, Lilly will have six manufacturing sites in Europe. The company said that it has announced $11 billion in investments in its worldwide manufacturing footprint over the past three years, Reuters reported.

Shares of Eli Lilly were up modestly Friday, and have added about two-thirds to their value this year.

Visit link:
Lilly To Build 1st Factory in Germany as Demand for Weight-Loss ... - Investopedia

Related Posts

    Your Full Name

    Your Email

    Your Phone Number

    Select your age (30+ only)

    Select Your US State

    Program Choice

    Confirm over 30 years old

    Yes

    Confirm that you resident in USA

    Yes

    This is a Serious Inquiry

    Yes

    Message:



    matomo tracker